Search

Your search keyword '"Antiviral agents -- Product introduction"' showing total 27 results
Start Over Descriptor "Antiviral agents -- Product introduction" Search Limiters Full Text
27 results on '"Antiviral agents -- Product introduction"'

2. Fitesa Launches Anti-Viral Product Line

Subjects
Cintas Corp. -- Product introduction -- Officials and employees, Antiviral agents -- Product introduction, Nonwoven fabrics -- Product introduction, Coronaviruses, Business, Fashion, accessories and textiles industries
Abstract

Following a series of investments designed to help in the fight against Covid-19, nonwovens producer Fitesa has expanded its product line to include an antiviral product line with a material [...]

Published
2021

3. United States : Trump EPA Approves First-Ever Long-Lasting Antiviral Product for Use Against COVID-19

Subjects
United States. Environmental Protection Agency, American Airlines Inc. -- Product introduction, Coronaviruses -- Health aspects, Antiviral agents -- Product introduction, Government agencies -- Health aspects, COVID-19 -- Health aspects, Business, international
Abstract

U.S. Environmental Protection Agency (EPA) Administrator Andrew Wheeler announced a groundbreaking development in the Trump Administrations efforts to combat the novel coronavirus. In a first-of-its kind step, EPA has issued [...]

Published
2020

4. Fujifilm's role in Ebola fight captures hope in a snapshot

Subjects
FUJIFILM Corp. -- Product introduction, Ebola virus infections -- Care and treatment -- Drug therapy, Antiviral agents -- Product introduction, Photographic industry -- Product introduction, International relations, Political science, Avigan (Medication) -- Product introduction
Abstract

When the Ebola outbreak of 2014 presented a significant threat to global security and killed thousands of people, panic started to set in. There were no drugs on the market [...]

Published
2016

5. FDA approves addition of new warnings to hep C drug label

Author

Talsma, Julia

Subjects
Antiviral agents -- Product introduction, Simeprevir -- Product introduction, Business, Pharmaceuticals and cosmetics industries
Abstract

FDA has approved label changes for the hepatitis C antiviral simeprevir (Olysio; Janssen) that will include new warnings about serious symptomatic bradycardia--slowing of the heart rate--when the drug is coadministered [...]

Published
2015

6. NEW DRUGS

Subjects
United States. Food and Drug Administration -- Laws, regulations and rules, Organon Inc. -- Product introduction -- Laws, regulations and rules, Salix Pharmaceuticals -- Product introduction, Axcan Scandipharm Inc. -- Product introduction, Schering-Plough Corp. -- Product introduction -- Laws, regulations and rules, Enzon Pharmaceuticals Inc. -- Product introduction -- Laws, regulations and rules, Hepatitis -- Laws, regulations and rules, Antiviral agents -- Product introduction, Contraceptives industry -- Product introduction, Pharmaceutical industry -- Product introduction, Oral contraceptives -- Product introduction, Government regulation, Business, Pharmaceuticals and cosmetics industries, Cyclessa (Contraceptive) -- Product introduction, Colazal (Medication) -- Product introduction, Canasa (Medication) -- Product introduction, Peg-Intron (Medication) -- Product introduction
Abstract

Organon Inc., West Orange, N.J., (800) 241-8812, has received FDA approval for Cyclessa (desogestrel/ethinyl estradiol oral contraceptive), the first low-dose (less than 30 mcg of estrogen) triphasic contraceptive. Cyclessa is [...]

Published
2001

7. UK drug update

Subjects
Novo Nordisk Pharmaceuticals Inc. -- Product introduction, Janssen-Cilag -- Product introduction, Sanofi Winthrop GmbH -- Product introduction, Dermal Laboratories Ltd. -- Product introduction, Ferring Pharmaceuticals -- Product introduction, Organon Laboratories (UK) -- Product introduction, Rosemont Pharmaceutical Corp. -- Product introduction, Abbott Laboratories (Abbott Park, Illinois) -- Product introduction, Product introduction, Hormones, Antiviral agents -- Product introduction, Hypoglycemic agents, Respiratory system agents, Contraceptives industry -- Product introduction, Pharmaceutical industry -- Product introduction, Contraceptives -- Product introduction, Respiratory agents
Abstract

Novo Nordisk Pharmaceuticals has introduced Novorapid injections. The vials, Penfill cartridges and Novolet prefilled syringe contain insulin aspart 100 units/ml. Dermal Laboratories has brought out an antimicrobial bath emollient. The [...]

Published
1999

8. INNOVATIONS

Subjects
Trimeris Inc. -- Product introduction, Pharmaceutical industry -- Innovations, Antiviral agents -- Product introduction, Antibiotics -- Product defects and recalls
Published
1999

9. New Rescriptor Pills

Subjects
Pharmacia & Upjohn Inc. -- Product introduction, Rescriptor (Medication) -- Product introduction, Antiviral agents -- Product introduction
Abstract

Rescriptor (delavirdine mesylate), indicated for the treatment of HIV infections in combination with antiretroviral agents, is now available in a 200-mg tablet size. The new tablets are smaller than the [...]

Published
1999

10. From antivirals to Viagra: drug review of '98

Subjects
Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction, Antibacterial agents -- Product introduction, Cardiovascular agents -- Product introduction, Business, Business, international, Chemicals, plastics and rubber industries, Engineering and manufacturing industries
Published
1999

11. New edition of WHO prequalification list to include four new anti-aids medicines

Subjects
Lamivudine -- Product introduction, Antiviral agents -- Product introduction, Anti-HIV agents -- Product introduction, Pharmaceutical industry -- Product introduction, Health, Science and technology, Product introduction
Abstract

Four new AIDS medicines are being added to the World Health Organization (WHO) prequalification list, thus further increasing access to a choice of quality products. At the same time, product [...]

Published
2004

12. A new drug for chronic hepatitis B in adults

Author

Aschenbrenner, Diane S.

Subjects
Hepatitis B -- Drug therapy, Antiviral agents -- Product introduction, Health, Tyzeka (Medication) -- Product introduction
Published
2007

13. Africa has now begun to manufacture generic AIDS drugs

Subjects
Aspen Pharmacare Holdings Ltd. -- Product introduction, Antiviral agents -- Product introduction, Anti-HIV agents -- Product introduction, Family and marriage, Health, Product introduction
Abstract

Africa has now begun to manufacture generic AIDS drugs. The South African company Aspen Pharmacare announced it is producing antiretrovirals containing stavudine--the generic version of Bristol-Meyers Squibb's Zerit. One month's [...]

Published
2003

15. Cold sores affect millions

Author

Cassell, Dana K.

Subjects
Cold sores -- Causes of, Cold sores -- Drug therapy, Herpes simplex -- Causes of, Herpes simplex -- Drug therapy, Antiviral agents -- Product introduction, Herpes simplex virus -- Health aspects, Herpes simplex virus -- Research, Pharmaceutical industry -- Product introduction
Abstract

In ancient Rome, an epidemic of cold sores (also known as fever blisters) prompted Emperor Tiberius to ban kissing in public ceremonies. Today, cold sores continue to present in epidemic [...]

Published
2009

16. Reese rollout

Subjects
Reese Pharmaceutical Co. -- Product introduction, Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Retail industry, OneTab (Medication) -- Product introduction
Abstract

Reese Pharmaceutical Co. has introduced a line of three O-T-C dye-flee cold- and flu-relief tablet products. Marketed under the brand name OneTab, the individual product offerings are for cold and [...]

Published
2009

17. Roche says that supplies of Tamiflu are adequate

Subjects
Hoffmann-La Roche Inc. -- Product introduction -- Company forecasts, Antiviral agents -- Product introduction, Pharmaceutical industry -- Company forecasts -- Product introduction, Company business forecast/projection, Business, Pharmaceuticals and cosmetics industries, Retail industry
Abstract

Hoffman-La Roche Inc. asserts that its Tamiflu antiviral flu medication will be in ample supply for the 2008/09 flu season. The product, known by its generic name of oseltamivir phosphate, [...]

Published
2008

18. Atripla™ (efavirenz 600 mg, emtricitabine 200 mg, and tenofovir disoproxil fumarate 300 mg)

Subjects
Bristol-Myers Squibb Co. -- Research agreements -- Product introduction, Gilead Sciences Inc. -- Research agreements -- Product introduction, Biological products industry -- Research agreements -- Product introduction, Antiviral agents -- Product introduction, Anti-HIV agents -- Product introduction, Pharmaceutical industry -- Research agreements -- Product introduction, Health, Atripla (Medication) -- Product introduction
Abstract

Bristol-Myers Squibb Company and Gilead Sciences, Inc Atripla combines two already-approved products--Bristol-Myers Squibb's Sustiva® and Gilead Science's Truvada®--in the first once-daily, single-dose regimen for the treatment of HW-1 in adults. [...]

Published
2006

19. PS debut

Subjects
Antibacterial agents -- Product introduction, Antiviral agents -- Product introduction, Pharmaceutical industry -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Retail industry
Abstract

American HomeHealth Inc. has created an 'infection prevention' category with its debut of PS. The brand incorporates a number of antiviral and antibacterial products to help consumers with their cleaning [...]

Published
2006

20. Combination HIV-1 drug approved

Subjects
GlaxoSmithKline PLC -- Product introduction, Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction
Abstract

Epzicom (abacavir/lamivudine) is approved for the treatment of HIV-1 infection. The formulation is a fixed-dose combination of the antiretroviral drugs abacavir sulfate (600 mg) and lamivudine (300 mg). For more [...]

Published
2004

21. Banishing bacteria

Author

Cozier, Muriel

Subjects
Perstorp AB -- Product introduction, Anti-infective agents -- Product introduction, Antiviral agents -- Product introduction, Chemical industry -- Product introduction, Herbicides -- Product introduction, Pesticides industry -- Product introduction, Business, Business, international, Chemicals, plastics and rubber industries
Abstract

Perstorp has introduced a series of antiviral and anti-microbial moulding compounds. Polygiene can be used to make a number of products including sanitaryware, handles, pens and public phones. The company [...]

Published
2004

22. Gilead Sciences. (UK Drug Update)

Subjects
Gilead Sciences Inc. -- Product introduction, Biological products industry -- Product introduction, Antiviral agents -- Product introduction, Business, Business, international, Chemicals, plastics and rubber industries, Engineering and manufacturing industries, Hepsera (Medication) -- Product introduction
Published
2003

23. Roche Products. (UK Drug Update)

Subjects
Roche Products Ltd. -- Product introduction, Influenza -- Drug therapy, Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction, Business, Business, international, Chemicals, plastics and rubber industries, Engineering and manufacturing industries, Tamiflu (Medication) -- Product introduction
Published
2003

24. Therapeutics

Subjects
Antiviral agents -- Product introduction, Analgesics -- Product introduction, Prostaglandins -- Usage, Business, Business, international, Chemicals, plastics and rubber industries, Engineering and manufacturing industries
Published
1992

25. FDA Approves Gilead's Tamiflu In Time For New Flu Season

Subjects
Gilead Sciences Inc. -- Product introduction, Glaxo Wellcome PLC -- Product introduction, Influenza -- Drug therapy, Antiviral agents -- Product introduction, Biotechnology industry
Abstract

With the Oct. 27 FDA approval of Hoffman-La Roche's oral neuraminidase inhibitor Tamiflu, consumers will have the choice between two drugs as the traditional flu season begins. Tamiflu, which was [...]

Published
1999

26. Agouron girds to join AIDS-drug battle: biotech firm's Viracept is a pricey late entry

Author

Rundle, Rhonda L.

Subjects
Agouron Pharmaceuticals Inc. -- Product introduction -- 00211436, Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction, AIDS (Disease) -- Drug therapy, Banking, finance and accounting industries, Business, Business, international, Viracept (Medication) -- Product introduction
Published
1997

27. Interferon approvals usher in biodrug era

Author

Robinson, Bill

Subjects
Hoffmann-La Roche Inc. -- Product introduction, Schering-Plough Corp. -- Product introduction, Interferon -- Product introduction, Pharmaceutical industry -- Product introduction, Leukemia -- Care and treatment, Antiviral agents -- Product introduction
Abstract

Interferon approvals usher in biodrug era The recent approval of interferon produced by genetic engineering sparked an unusual excitement as the new age of biotherapeautics became suddenly real in the [...]

Published
1986

Catalog

Books, media, physical & digital resources
See catalog results